News on Antiphospholipid from BioPortfolio.com http://www.BioPortfolio.com Consolidated Antiphospholipid news from BioPortfolio.com Tue, 09 Feb 2010 17:24:42 GMT en Antiphospholipid antibodies and malignancieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996623&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996623&THISHREF=http://c.moreover.com/click/here.pl%3fz2516388112%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996623&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996623&THISHREF=http://c.moreover.com/click/here.pl%3fz2516388112%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Antiphospholipid Syndrome and Acute HIV Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971500&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971500&THISHREF=http://c.moreover.com/click/here.pl%3fz2501905724%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971500&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971500&THISHREF=http://c.moreover.com/click/here.pl%3fz2501905724%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCenter for Disease Control and Prevention: Use of Rituximab in the Antiphospholipid Syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968288&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968288&THISHREF=http://c.moreover.com/click/here.pl%3fz2500280222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968288&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968288&THISHREF=http://c.moreover.com/click/here.pl%3fz2500280222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: High risk for recurrent TE in APS patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924098&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924098&THISHREF=http://c.moreover.com/click/here.pl%3fz2476875971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924098&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924098&THISHREF=http://c.moreover.com/click/here.pl%3fz2476875971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Influence of gender on the clinical and laboratory spectra of patients with primary antiphospholipid syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906432&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906432&THISHREF=http://c.moreover.com/click/here.pl%3fz2466918669%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906432&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906432&THISHREF=http://c.moreover.com/click/here.pl%3fz2466918669%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Primary antiphospholipid syndrome with recurrent coronary thrombosis, acute pulmonary thromboembolism and intrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3875717&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3875717&THISHREF=http://c.moreover.com/click/here.pl%3fz2451085422%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3875717&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3875717&THISHREF=http://c.moreover.com/click/here.pl%3fz2451085422%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Invasive Cardiology: Pregnancy outcome in different clinical phenotypes of antiphospholipid syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3873507&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3873507&THISHREF=http://c.moreover.com/click/here.pl%3fz2450037021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3873507&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antiphospholipid&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3873507&THISHREF=http://c.moreover.com/click/here.pl%3fz2450037021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: